Quad-Cities Investment Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.03M | Buy |
4,077
+2
| +0% | +$430 | 0.37% | 65 |
|
|
2026
Q1 | $886K | Sell |
4,075
-48
| -1% | -$10.6K | 0.35% | 68 |
|
|
2025
Q4 | $942K | Sell |
4,123
-46
| -1% | -$10.5K | 0.39% | 58 |
|
|
2025
Q3 | $965K | Buy |
4,169
+36
| +0.9% | +$7.33K | 0.41% | 59 |
|
|
2025
Q2 | $767K | Buy |
4,133
+73
| +2% | +$13.6K | 0.35% | 67 |
|
|
2025
Q1 | $851K | Buy |
4,060
+1
| +0% | +$194 | 0.42% | 56 |
|
|
2024
Q4 | $721K | Buy |
4,059
+2
| +0% | +$368 | 0.35% | 66 |
|
|
2024
Q3 | $801K | Sell |
4,057
-48
| -1% | -$8.96K | 0.4% | 60 |
|
|
2024
Q2 | $704K | Buy |
4,105
+2
| +0% | +$331 | 0.39% | 64 |
|
|
2024
Q1 | $747K | Sell |
4,103
-48
| -1% | -$8.27K | 0.44% | 58 |
|
|
2023
Q4 | $670K | Buy |
4,151
+585
| +16% | +$85.3K | 0.41% | 60 |
|
|
2023
Q3 | $532K | Buy |
3,566
+152
| +4% | +$22.3K | 0.36% | 74 |
|
|
2023
Q2 | $460K | Buy |
3,414
+2
| +0.1% | +$293 | 0.3% | 85 |
|
|
2023
Q1 | $544K | Sell |
3,412
-33
| -1% | -$5.04K | 0.38% | 64 |
|
|
2022
Q4 | $557K | Sell |
3,445
-377
| -10% | -$57.8K | 0.41% | 61 |
|
|
2022
Q3 | $513K | Buy |
3,822
+102
| +3% | +$14.6K | 0.4% | 66 |
|
|
2022
Q2 | $570K | Buy |
3,720
+2
| +0.1% | +$306 | 0.42% | 63 |
|
|
2022
Q1 | $603K | Buy |
3,718
+2
| +0.1% | +$291 | 0.39% | 69 |
|
|
2021
Q4 | $503K | Buy |
3,716
+2
| +0.1% | +$236 | 0.31% | 85 |
|
|
2021
Q3 | $401K | Sell |
3,714
-28
| -0.7% | -$3.2K | 0.28% | 92 |
|
|
2021
Q2 | $421K | Buy |
3,742
+34
| +0.9% | +$3.83K | 0.29% | 98 |
|
|
2021
Q1 | $401K | Sell |
3,708
-298
| -7% | -$31.9K | 0.3% | 93 |
|
|
2020
Q4 | $429K | Sell |
4,006
-281
| -7% | -$27K | 0.35% | 84 |
|
|
2020
Q3 | $376K | Buy |
4,287
+106
| +3% | +$9.98K | 0.36% | 79 |
|
|
2020
Q2 | $411K | Buy |
4,181
+117
| +3% | +$10.3K | 0.42% | 70 |
|
|
2020
Q1 | $310K | Buy |
4,064
+352
| +9% | +$30K | 0.4% | 82 |
|
|
2019
Q4 | $331K | Buy |
3,712
+2
| +0.1% | +$166 | 0.31% | 97 |
|
|
2019
Q3 | $281K | Buy |
3,710
+102
| +3% | +$6.99K | 0.24% | 102 |
|
|
2019
Q2 | $264K | Sell |
3,608
-398
| -10% | -$31.3K | 0.23% | 101 |
|
|
2019
Q1 | $322K | Buy |
4,006
+202
| +5% | +$16.5K | 0.29% | 87 |
|
|
2018
Q4 | $351K | Buy |
3,804
+1
| +0% | +$88 | 0.36% | 66 |
|
|
2018
Q3 | $359K | Buy |
3,803
+1
| +0% | +$95 | 0.32% | 76 |
|
|
2018
Q2 | $353K | Buy |
3,802
+2
| +0.1% | +$195 | 0.33% | 71 |
|
|
2018
Q1 | $359K | Buy |
+3,800
| New | +$417K | 0.46% | 65 |
|
Other funds holding ABBV
Quad-Cities Investment Group's ABBV Position: Q2 2026 in Review
Quad-Cities Investment Group increased its AbbVie (ABBV) stake by 0.05% in Q2 2026, buying an estimated $430 and bringing the position to 4,077 shares worth $1.03M. The position accounts for 0.37% of the portfolio, ranked #65.
Quad-Cities Investment Group first reported a position in ABBV in Q1 2018 and has held it in 34 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Quad-Cities Investment Group held 4,077 shares of AbbVie worth $1.03M as of Q2 2026.
- Quad-Cities Investment Group bought 2 AbbVie shares in Q2 2026, an estimated $430.
- AbbVie made up 0.37% of Quad-Cities Investment Group's portfolio in Q2 2026, its #65 holding.
- Quad-Cities Investment Group first reported a position in AbbVie in Q1 2018 and has held it in 34 quarters since.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Quad-Cities Investment Group's 13F filing for Q2 2026, filed 7 Jul 2026.